Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Development of Pan-filovirus T cell vaccines against Ebola and Marburg virus challenges

Conference paper

Qiu X. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1664 - 1664

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

Journal article

Broset E. et al, (2019), Molecular Therapy - Methods and Clinical Development, 13, 253 - 264

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

Conference paper

Thornhill J. et al, (2019), HIV MEDICINE, 20, 7 - 7

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Journal article

Moyo N. et al, (2019), Molecular Therapy - Methods and Clinical Development, 12, 32 - 46

Construction and Characterization of Recombinant MTBVAC. HIV, a New Live Attenuated Vaccine Against HIV and Tuberculosis

Conference paper

Saubi N. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 314 - 314

Control of HIV-1 by CD8+T Cells Specific for Epitopes of Conserved Mosaic Vaccine Immunogens

Conference paper

Murakoshi H. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 172 - 172

Recombinant BCG: tHIVconsvX Prime-ChAdOx: tHIVconsvX Boost Regimen Was Safe, Stable and Elicited Specific HIV-1 T-cell Immune Responses in BALB/C Mice

Conference paper

Kilpelainen A. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 327 - 327

Identification of novel HIV-1-derived HLA-E-binding peptides.

Journal article

Hannoun Z. et al, (2018), Immunol Lett

Load More